Gene Sequencing Market Growth Analysis, Market Dynamics, Key Players and Innovations, Outlook and Fo

• Global gene sequencing market was valued at USD 21.67 billion in 2024 and is projected to grow from USD 23.15 billion in 2025 to USD 74.61 billion by 2032, exhibiting a robust CAGR of 19.4% during the forecast period.

Email:  help@intelmarketresearch.com +91 9169164321

Report Studies

• Gene sequencing is a laboratory technique that determines the precise order of nucleotides within a DNA molecule. This process enables comprehensive analysis of genetic information, providing critical insights into biological functions, disease mechanisms, and hereditary patterns. Modern sequencing technologies, particularly next-generation sequencing (NGS), have revolutionized the field by enabling high-throughput, cost-effective genomic analysis at unprecedented scales.

Email:  help@intelmarketresearch.com +91 9169164321

By Types

•Next-generation sequencing (NGS)

•Third and fourth generation sequencing

•First-generation sequencing

•Others

By Applications

• Academic research

• Drug Discovery & Development

• Agricultural & Animal Genomics

• Forensics

• Reproductive Health (NIPT, carrier screening)

• Personalized Medicine

• Others

Email:  help@intelmarketresearch.com

• Illumina, Inc. (U.S.)

• Thermo Fisher Scientific (U.S.)

• Eurofins Scientific (Luxembourg)

• BGI Genomics (China)

• Natera, Inc. (U.S.)

• Berry Genomics (China)

• Roche Holding AG (Switzerland)

• Novogene Corporation (China)

Email:  help@intelmarketresearch.com +91 9169164321